Not applicableAvailableNCT07332338
What this trial is testing
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
Who this might be right for
Post-COVID-19 ConditionPost-COVID ConditionPost-COVID Syndrome+4 more
StemCyte, Inc.